Drugs in Dev.
Obstetrics/Gynecology (Women’s Health)
Undisclosed
Sweden 
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Oxytocin
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Undisclosed
Sponsor : Monash University
Deal Size : $1.0 million
Deal Type : Collaboration
Iconovo Signs Agreement for Development of Inhaled Oxytocin in ICOone For Maternal Health
Details : The agreement gives Monash an exclusive global right to use ICOone with oxytocin to prevent postpartum haemorrhage in women giving birth.
Product Name : ICOone
Product Type : Hormone
Upfront Cash : Undisclosed
December 21, 2020
Lead Product(s) : Oxytocin
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Undisclosed
Sponsor : Monash University
Deal Size : $1.0 million
Deal Type : Collaboration

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Adding Antioxidants Into Human Sequential Culture Media System
Details : This drug candidate is currently being evaluated in clinical studies for the treatment of Blastocyst.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
December 21, 2016
Lead Product(s) : Undisclosed
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
